title: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.
authors.forename: A F
authors.initials: AF
authors.lastname: List
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: M A
authors.initials: MA
authors.lastname: Sekeres
authors.forename: B
authors.initials: B
authors.lastname: Skikne
authors.forename: T
authors.initials: T
authors.lastname: Fu
authors.forename: J M
authors.initials: JM
authors.lastname: Shammo
authors.forename: S D
authors.initials: SD
authors.lastname: Nimer
authors.forename: R D
authors.initials: RD
authors.lastname: Knight
authors.forename: A
authors.initials: A
authors.lastname: Giagounidis